Insights

Gathering insights about Precirix…

Similar companies to Precirix

Precirix Tech Stack

Precirix uses 8 technology products and services including Craft CMS, SAP, React, and more. Explore Precirix's tech stack below.

Craft CMS
Content Management System
SAP
Customer Relationship Management
React
Javascript Frameworks
X-Content-Type-Options
Miscellaneous
PHP
Programming Languages
SEOmatic
Search Engines
HSTS
Security
Google Tag Manager
Tag Management

Media & News

Precirix NV launched CAM-FAP-Ga-68 Academic Access Program on Aug 26th '24.
Precirix launches CAM-FAP-Ga-68 Academic Access Program.
Aug 27, 2024 | www.healthcap.eu
Precirix NV hired Tom Plitz as CEO on Mar 6th '24.
Brussels, Belgium, 29 February 2024 - Precirix, a biotechnology company developing precision radiopharmaceuticals in oncology, today announces that Tom Plitz has been appointed CEO of the company.
Mar 06, 2024 | precirix.com
Jeito and Forbion invested into Precirix NV $89.8M on Jan 1st '22.
Precirix successfully closed a EUR 80m Series B financing round in 2022 with new investors INKEF Capital, Jeito Capital and Forbion and participation of existing shareholders Gimv, HealthCap, Novo Holdings, Pontifax Venture Capital, V-Bio Ventures, BioMed Partners, as well as the seed investors, allowing the company to advance its pipeline and expand its teams.
Jul 19, 2023 | precirix.com
Precirix NV partners with Eckert & Ziegler AG.
Precirix enters into collaboration with Eckert & Ziegler for the development of its 68Ga-based compounds.
Dec 08, 2022 | precirix.com
Precirix NV is developing novel precision radiopharmaceuticals using single-domain antibodies.
"Precirix is developing novel precision radiopharmaceuticals using single-domain antibodies to address the high unmet need in the treatment of solid tumors.
Jul 25, 2022 | www.precirix.com
Forbion European Acquisition Corp invested into Precirix NV $88.1M on Mar 16th '22.
Precirix NV, a clinical-stage biotechnology company developing precision radiopharmaceuticals in oncology, today announces the closing of a EUR 80m Series B financing round led by new investor INKEF Capital, alongside Jeito Capital and Forbion Capital Partners.
Mar 16, 2022 | www.bva.be
Precirix NV received financing of $40M in Series A on Mar 16th '18.
Belgian biotech upstart Precirix had raised $40 million in a Series A from 6 VC backers four years ago.
Mar 16, 2022 | endpts.com

Precirix's Email Address Formats

Precirix uses at least 2 format(s):

Precirix Email Formats	Example	Percentage
First.Last@camel-ids.com	John.Doe@camel-ids.com	92%
First.Middle.Last@camel-ids.com	John.Michael.Doe@camel-ids.com	8%
First.Last@precirix.com	John.Doe@precirix.com	71%
Last@precirix.com	Doe@precirix.com	29%

Frequently Asked Questions

Where is Precirix's headquarters located?

Precirix's main headquarters is located at Burgemeester Etienne Demunterlaan 1 Brussels, 1090 BE. The company has employees across 4 continents, including EuropeAsiaNorth America.

What is Precirix's official website and social media links?

Precirix's official website is precirix.com and has social profiles on LinkedIn.

How much revenue does Precirix generate?

As of November 2024, Precirix's annual revenue reached $7.5M.

What is Precirix's SIC code NAICS code?

Precirix's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Precirix have currently?

As of November 2024, Precirix has approximately 35 employees across 4 continents, including EuropeAsiaNorth America. Key team members include Chief Technology Officer: D. M.Chief Operating Officer: J. G.Head Of Alliance And Program Management: J. D. V.. Explore Precirix's employee directory with LeadIQ.

What industry does Precirix belong to?

Precirix operates in the Biotechnology Research industry.

What technology does Precirix use?

Precirix's tech stack includes Craft CMSSAPReactX-Content-Type-OptionsPHPSEOmaticHSTSGoogle Tag Manager.

What is Precirix's email format?

Precirix's email format typically follows the pattern of . Find more Precirix email formats with LeadIQ.

How much funding has Precirix raised to date?

As of November 2024, Precirix has raised $88M in funding. The last funding round occurred on Mar 16, 2022 for $88M.

When was Precirix founded?

Precirix was founded in 2014.

Precirix

Biotechnology ResearchBrussels, Belgium11-50 Employees

PRECIRIX® is a clinical-stage biotechnology company dedicated to improving the lives of cancer patients by developing novel targeted radiopharmaceuticals using camelid single domain antibody fragments.

The company is advancing its lead product CAM-H2 through a Phase I/II clinical trial targeting HER2-positive tumors, while further progressing and broadening its oncology pipeline.

PRECIRIX' technology platform allows for a theranostic approach, using the same molecule for patient selection (imaging) and therapy.

Company Overview

Headquarters: Burgemeester Etienne Demunterlaan 1 Brussels, 1090 BE
Website: precirix.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2014
Employees: 11-50

Media & News

Funding & Financials

$88M
Precirix has raised a total of $88M of funding over 2 rounds. Their latest funding round was raised on Mar 16, 2022 in the amount of $88M.
$10M
Precirix's revenue is in the range of $10M

Funding & Financials

$88M
Precirix has raised a total of $88M of funding over 2 rounds. Their latest funding round was raised on Mar 16, 2022 in the amount of $88M.
$10M
Precirix's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Precirix

OncoResponse

Acticor Biotech

Indapta Therapeutics

Treeway

Nanobiotix

Precirix Tech Stack

Media & News

Precirix NV launched CAM-FAP-Ga-68 Academic Access Program on Aug 26th '24.

Precirix NV hired Tom Plitz as CEO on Mar 6th '24.

Jeito and Forbion invested into Precirix NV $89.8M on Jan 1st '22.

Precirix NV partners with Eckert & Ziegler AG.

Precirix NV is developing novel precision radiopharmaceuticals using single-domain antibodies.

Forbion European Acquisition Corp invested into Precirix NV $88.1M on Mar 16th '22.

Precirix NV received financing of $40M in Series A on Mar 16th '18.

Precirix's Email Address Formats

Frequently Asked Questions

Where is Precirix's headquarters located?

What is Precirix's official website and social media links?

How much revenue does Precirix generate?

What is Precirix's SIC code NAICS code?

How many employees does Precirix have currently?

What industry does Precirix belong to?

What technology does Precirix use?

What is Precirix's email format?

How much funding has Precirix raised to date?

When was Precirix founded?

Precirix

Company Overview

Media & News

Precirix NV launched CAM-FAP-Ga-68 Academic Access Program on Aug 26th '24.

Precirix NV hired Tom Plitz as CEO on Mar 6th '24.

Jeito and Forbion invested into Precirix NV $89.8M on Jan 1st '22.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?